195 related articles for article (PubMed ID: 21426923)
21. [Solubilization and complexation of the antileukotrienic drug Quinlukast in aqueous solutions of cyclodextrins].
Kopecký F; Kopecká B
Ceska Slov Farm; 2005 May; 54(3):137-40. PubMed ID: 15945461
[TBL] [Abstract][Full Text] [Related]
22. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
[TBL] [Abstract][Full Text] [Related]
23. Inclusion complex of barbigerone with hydroxypropyl-β-cyclodextrin: preparation and in vitro evaluation.
Qiu N; Cheng X; Wang G; Wang W; Wen J; Zhang Y; Song H; Ma L; Wei Y; Peng A; Chen L
Carbohydr Polym; 2014 Jan; 101():623-30. PubMed ID: 24299819
[TBL] [Abstract][Full Text] [Related]
24. Studies of inclusion complexes of natural and modified cyclodextrin with (+)catechin by NMR and molecular modeling.
Jullian C; Miranda S; Zapata-Torres G; Mendizábal F; Olea-Azar C
Bioorg Med Chem; 2007 May; 15(9):3217-24. PubMed ID: 17350847
[TBL] [Abstract][Full Text] [Related]
25. Study on the complexation of isoquercitrin with beta-cyclodextrin and its derivatives by spectroscopy.
Wang Y; Qiao X; Li W; Zhou Y; Jiao Y; Yang C; Dong C; Inoue Y; Shuang S
Anal Chim Acta; 2009 Sep; 650(1):124-30. PubMed ID: 19720183
[TBL] [Abstract][Full Text] [Related]
26. 2-Hydroxypropyl-beta-cyclodextrin (HP-beta-CD): a toxicology review.
Gould S; Scott RC
Food Chem Toxicol; 2005 Oct; 43(10):1451-9. PubMed ID: 16018907
[TBL] [Abstract][Full Text] [Related]
27. [Dissolution and signs of supersaturation of nimodipine in aqueous solutions of the cyclodextrins, alpha-CD, HP-alpha-CD, M-beta-CD and HP-gamma-CD].
Kopecký F; Kopecká B; Kaclík P
Ceska Slov Farm; 1999 Nov; 48(6):287-90. PubMed ID: 10748748
[TBL] [Abstract][Full Text] [Related]
28. Formation of natamycin:cyclodextrin inclusion complexes and their characterization.
Koontz JL; Marcy JE
J Agric Food Chem; 2003 Nov; 51(24):7106-10. PubMed ID: 14611179
[TBL] [Abstract][Full Text] [Related]
29. Preclinical comparison of intravenous melphalan pharmacokinetics administered in formulations containing either (SBE)7 m-β-cyclodextrin or a co-solvent system.
Koltun M; Morizzi J; Katneni K; Charman SA; Shackleford DM; McIntosh MP
Biopharm Drug Dispos; 2010 Nov; 31(8-9):450-4. PubMed ID: 20865695
[TBL] [Abstract][Full Text] [Related]
30. Sparing methylation of beta-cyclodextrin mitigates cytotoxicity and permeability induction in respiratory epithelial cell layers in vitro.
Salem LB; Bosquillon C; Dailey LA; Delattre L; Martin GP; Evrard B; Forbes B
J Control Release; 2009 Jun; 136(2):110-6. PubMed ID: 19331849
[TBL] [Abstract][Full Text] [Related]
31. Curve-fitting FTIR studies of loratadine/hydroxypropyl-beta-cyclodextrin inclusion complex induced by co-grinding process.
Lin SY; Hsu CH; Sheu MT
J Pharm Biomed Anal; 2010 Nov; 53(3):799-803. PubMed ID: 20619996
[TBL] [Abstract][Full Text] [Related]
32. Characterization of the 13-cis-retinoic acid/cyclodextrin inclusion complexes by phase solubility, photostability, physicochemical and computational analysis.
Yap KL; Liu X; Thenmozhiyal JC; Ho PC
Eur J Pharm Sci; 2005 May; 25(1):49-56. PubMed ID: 15854800
[TBL] [Abstract][Full Text] [Related]
33. Release of testosterone from an osmotic pump tablet utilizing (SBE)7m-beta-cyclodextrin as both a solubilizing and an osmotic pump agent.
Okimoto K; Rajewski RA; Stella VJ
J Control Release; 1999 Mar; 58(1):29-38. PubMed ID: 10021487
[TBL] [Abstract][Full Text] [Related]
34. Intestinal safety of water-soluble beta-cyclodextrins in paediatric oral solutions of spironolactone: effects on human intestinal epithelial Caco-2 cells.
Tötterman AM; Schipper NG; Thompson DO; Mannermaa JP
J Pharm Pharmacol; 1997 Jan; 49(1):43-8. PubMed ID: 9120769
[TBL] [Abstract][Full Text] [Related]
35. Solubilization of a naphthoquinone derivative by hydroxypropyl-beta-cyclodextrin (HP-beta-CD) and polyvinylpyrrolidone (PVP-K30). The influence of PVP-K30 and pH on solubilizing effect of HP-beta-CD.
Granero G; de Bertorello MM; Longhi M
Boll Chim Farm; 2002; 141(1):63-6. PubMed ID: 12064060
[TBL] [Abstract][Full Text] [Related]
36. Molecular dynamics study of the inclusion of cholesterol into cyclodextrins.
Yu Y; Chipot C; Cai W; Shao X
J Phys Chem B; 2006 Mar; 110(12):6372-8. PubMed ID: 16553456
[TBL] [Abstract][Full Text] [Related]
37. Comparative in vitro and in vivo taste assessment of liquid praziquantel formulations.
Münster M; Mohamed-Ahmed AHA; Immohr LI; Schoch C; Schmidt C; Tuleu C; Breitkreutz J
Int J Pharm; 2017 Aug; 529(1-2):310-318. PubMed ID: 28689966
[TBL] [Abstract][Full Text] [Related]
38. Improvement of some pharmaceutical properties of DY-9760e by sulfobutyl ether beta-cyclodextrin.
Nagase Y; Hirata M; Wada K; Arima H; Hirayama F; Irie T; Kikuchi M; Uekama K
Int J Pharm; 2001 Oct; 229(1-2):163-72. PubMed ID: 11604269
[TBL] [Abstract][Full Text] [Related]
39. In vitro and in vivo evaluation of a sulfobutyl ether beta-cyclodextrin enabled etomidate formulation.
McIntosh MP; Schwarting N; Rajewski RA
J Pharm Sci; 2004 Oct; 93(10):2585-94. PubMed ID: 15349968
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of a sulfobutyl ether beta-cyclodextrin as a solubilizing/stabilizing agent for several drugs.
Ueda H; Ou D; Endo T; Nagase H; Tomono K; Nagai T
Drug Dev Ind Pharm; 1998 Sep; 24(9):863-7. PubMed ID: 9876538
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
